Skip to main content

Table 2 Adverse events

From: Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study

 

Grade 1

Grade 2

Grade 3

Grade 4

Adverse Reactions at least possibly related to glucarpidase (All)

Abdominal pain

1 (2)

Dyspnea

1 (2)

Fecal incontinence

1 (2)

Flushed face

1 (2)

Headache

1 (2)

Nausea

3 (5)

Adverse Reactions at least possibly related to methotrexate (All grade 3 and higher, most common > 10% grade 1–2)

Alanine aminotransferase increased

12 (22)

2 (4)

1 (2)

Anemia

10 (18)

12 (22)

5 (9)

Aspartate aminotransferase increased

17 (31)

2 (4)

1 (2)

Blood billirubin increased

11 (20)

3 (5)

Creatinine increased

2 (4)

3 (5)

Hypoalbuminemia

10 (18)

2 (4)

Hypokalemia

7 (13)

1 (2)

2 (4)

Lung infection

1 (2)

Lymphocyte count decreased

7 (13)

15 (27)

10 (18)

Nausea

8 (15)

4 (7)

White blood cell count decreased

8 (15)

3 (5)

1 (2)

  1. -, not observed